291 related articles for article (PubMed ID: 8740320)
1. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
[TBL] [Abstract][Full Text] [Related]
2. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
[TBL] [Abstract][Full Text] [Related]
3. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
[TBL] [Abstract][Full Text] [Related]
4. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
ter Heine R; van Maarseveen EM; van der Westerlaken MM; Braun KP; Koudijs SM; Berg MJ; Malingré MM
J Child Neurol; 2014 Jun; 29(6):803-10. PubMed ID: 23670246
[TBL] [Abstract][Full Text] [Related]
5. Altered phenytoin pharmacokinetics in children with severe, acute traumatic brain injury.
Stowe CD; Lee KR; Storgion SA; Phelps SJ
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1452-61. PubMed ID: 11185666
[TBL] [Abstract][Full Text] [Related]
6. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient.
Mlynarek ME; Peterson EL; Zarowitz BJ
Ann Pharmacother; 1996 Mar; 30(3):219-23. PubMed ID: 8833553
[TBL] [Abstract][Full Text] [Related]
7. The predictive performances of equations used to estimate unbound phenytoin concentrations in a medical ICU population and the impact of exogenous albumin administration.
Parikh L; MacLaren R
J Crit Care; 2018 Apr; 44():95-100. PubMed ID: 29078132
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
Lynn K; Braithwaite R; Dawling S; Rosser R
Eur J Clin Pharmacol; 1981 Jan; 19(1):73-7. PubMed ID: 7461027
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute phase response on phenytoin metabolism in neurotrauma patients.
McKindley DS; Boucher BA; Hess MM; Rodman JH; Feler C; Fabian TC
J Clin Pharmacol; 1997 Feb; 37(2):129-39. PubMed ID: 9055139
[TBL] [Abstract][Full Text] [Related]
10. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
[TBL] [Abstract][Full Text] [Related]
11. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of unbound phenytoin in the management of epilepsy.
Kilpatrick CJ; Wanwimolruk S; Wing LM
Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin removal by continuous venovenous hemofiltration.
Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
[TBL] [Abstract][Full Text] [Related]
14. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
15. Unbound fraction of ertapenem in intensive care unit patients.
Liebchen U; Kratzer A; Wicha SG; Kees F; Kloft C; Kees MG
J Antimicrob Chemother; 2014 Nov; 69(11):3108-11. PubMed ID: 24962030
[TBL] [Abstract][Full Text] [Related]
16. Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.
Riker RR; Gagnon DJ; Hatton C; May T; Seder DB; Stokem K; Fraser GL
Pharmacotherapy; 2017 Apr; 37(4):500-508. PubMed ID: 28173638
[TBL] [Abstract][Full Text] [Related]
17. Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation.
Kane SP; Bress AP; Tesoro EP
Ann Pharmacother; 2013 May; 47(5):628-36. PubMed ID: 23606554
[TBL] [Abstract][Full Text] [Related]
18. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
Oellerich M; Müller-Vahl H
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
[TBL] [Abstract][Full Text] [Related]
19. Disposition of phenytoin in critically ill trauma patients.
Boucher BA; Rodman JH; Fabian TC; Cupit GC; Ludden TM; West ME; Ray MW
Clin Pharm; 1987 Nov; 6(11):881-7. PubMed ID: 3677565
[TBL] [Abstract][Full Text] [Related]
20. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
Van Peer AP; Belpaire FM; Rosseel MT; Bogaert MG
Pharmacology; 1981; 22(2):139-45. PubMed ID: 7208595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
